retatrutide glucagon receptor agonist The data just dropped — and is rewriting what's possible in obesity medicine. 🧬 TRIUMPH-1 just released Phase 3 results, and the numbers are unlike anything we've seen from a medication JK - 🔬 EDUCATIONAL POST:

It comes from licensed 503A pharmacies, requires no insurance, and is available in all 50 states

For example, we dont yet understand how somebodys microbiome may influence how well they respond to GLP-1 drugs or the degree to which they suffer from side effects. Added to this, research hasnt yet determined how a users gut microbiome changes when they take these drugs and what impact that could have

AskarpourMHadiASymondsMEMiraghajaniMOmidSSheikhiAet alEfficacy of L-carnitine supplementation for management of blood lipids: A systematic review and dose-response meta-analysis of randomized controlled trials

In most cases, requiring members to enroll in a lifestyle modification program or limiting the prescribing of the drugs to certain specialists would result in a loss of rebates for GLP-1s for weight loss

Targeting TGF- signaling to alleviate obesity Despite significant advances in understanding the role of the TGF- pathway in obesity, obesity-induced diseases, and cancer, critical questions remain about whether this pathway functions predominantly as a driver or suppressor in these conditions